Evidence map›Paper›PMID 29764418›Full record

ArticleMicrobial cell factories2018

Engineering xylose metabolism for production of polyhydroxybutyrate in the non-model bacterium Burkholderia sacchari.

Linda P Guamán, Carlos Barba-Ostria, Fuzhong Zhang, Edmar R Oliveira-Filho, José Gregório C Gomez, Luiziana F Silva

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Current landscape and future directions of synthetic biology in South America.Frontiers in bioengineering and biotechnology · 2023
    Review
  4. Article
  5. Review
  6. Introduction of Modified BglBrick System inFrontiers in bioengineering and biotechnology · 2021
    Article
  7. Engineering the Osmotic State ofFrontiers in bioengineering and biotechnology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 4 countries.

Linda P GuamánUniversidad Tecnológica Equinoccial, Centro de Investigación Biomédica, Facultad de Ciencias de la Salud Eugenio Espejo, Quito, Ecuador.
Carlos Barba-OstriaDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, Av Prof Lineu Prestes 1374 Lab 148, Cidade Universitária, São Paulo, SP, 05508-888, Brazil.
Fuzhong ZhangDepartment of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, Saint Louis, MO, 63130, USA.
Edmar R Oliveira-FilhoDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, Av Prof Lineu Prestes 1374 Lab 148, Cidade Universitária, São Paulo, SP, 05508-888, Brazil.ORCID http://orcid.org/0000-0002-1597-0830
José Gregório C GomezDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, Av Prof Lineu Prestes 1374 Lab 148, Cidade Universitária, São Paulo, SP, 05508-888, Brazil.
Luiziana F SilvaDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, Av Prof Lineu Prestes 1374 Lab 148, Cidade Universitária, São Paulo, SP, 05508-888, Brazil. lukneif@usp.br.
Universidade de São Paulo · BRWashington University in St. Louis · US

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 140321/2017-9Conselho Nacional de Desenvolvimento Científico e Tecnológico 454371/2014-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2010/51989-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/00842-0Secretaría de Educación Superior, Ciencia, Tecnología e Innovación PhD ScholarshipUniversidad Técnica de Ambato, Ecuador, through Department of Research and Development (DIDE) 0932-CU-P-2016Universidad Técnica de Ambato, Ecuador, through Department of Research and Development (DIDE) 2456-CU-P-2017
6 · The paper itself

Abstract

backgroundDespite its ability to grow and produce high-value molecules using renewable carbon sources, two main factors must be improved to use Burkholderia sacchari as a chassis for bioproduction at an industrial scale: first, the lack of molecular tools to engineer this organism and second, the inherently slow growth rate and poly-3-hydroxybutyrate [P(3HB)] production using xylose. In this work, we have addressed both factors.

resultsFirst, we adapted a set of BglBrick plasmids and showed tunable expression in B. sacchari. Finally, we assessed growth rate and P(3HB) production through overexpression of xylose transporters, catabolic or regulatory genes. Overexpression of xylR significantly improved growth rate (55.5% improvement), polymer yield (77.27% improvement), and resulted in 71% of cell dry weight as P(3HB).

conclusionsThese values are unprecedented for P(3HB) accumulation using xylose as a sole carbon source and highlight the importance of precise expression control for improving utilization of hemicellulosic sugars in B. sacchari.

Indexed as

BioengineeringBurkholderiaHydroxybutyratesPolyestersPolyhydroxybutyratesXyloseHydroxybutyratespoly-beta-hydroxybutyratePolyestersPolyhydroxybutyratesXyloseBglBricksBurkholderiaP(3HB)XylosexylR

Identifiers

PMID29764418
PMCPMC5952831
OpenAlexW2806616369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.